Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Neuro-Oncology
|
November 18, 2021
Consensus core clinical data elements for meningiomas (v2021.1)
Farshad Nassiri, Justin Z Wang, Karolyn Au, et al.
Neuro-Oncology
|
May 13, 2021
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
Hao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, et al.
The Lancet. Oncology
|
June 8, 2013
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
Ian F Tannock, Karim Fizazi, Sergey Ivanov, et al.
Neuro-Oncology
|
May 31, 2022
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
Macarena I de la Fuente, Howard Colman, Mark Rosenthal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2013
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma
Tracy T Batchelor, Paul Mulholland, Bart Neyns, et al.
JNCI Cancer Spectrum
|
May 6, 2020
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel
Susan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Neuro-Oncology
|
December 21, 2022
Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26
Karen Alpen, Claire M Vajdic, Robert J MacInnis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2018
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel
Susan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Pediatric Pulmonology
|
July 28, 2023
Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB-CF study
Claire Edmondson, Nicole Westrupp, Christopher Short, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2016
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
Susan Halabi, William Kevin Kelly, Hua Ma, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Neuro-Oncology
|
November 18, 2021
Consensus core clinical data elements for meningiomas (v2021.1)
Farshad Nassiri, Justin Z Wang, Karolyn Au, et al.
Neuro-Oncology
|
May 13, 2021
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
Hao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, et al.
The Lancet. Oncology
|
June 8, 2013
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
Ian F Tannock, Karim Fizazi, Sergey Ivanov, et al.
Neuro-Oncology
|
May 31, 2022
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
Macarena I de la Fuente, Howard Colman, Mark Rosenthal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2013
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma
Tracy T Batchelor, Paul Mulholland, Bart Neyns, et al.
JNCI Cancer Spectrum
|
May 6, 2020
Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel
Susan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Neuro-Oncology
|
December 21, 2022
Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26
Karen Alpen, Claire M Vajdic, Robert J MacInnis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2018
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel
Susan Halabi, Sandipan Dutta, Catherine M Tangen, et al.
Pediatric Pulmonology
|
July 28, 2023
Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB-CF study
Claire Edmondson, Nicole Westrupp, Christopher Short, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2016
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
Susan Halabi, William Kevin Kelly, Hua Ma, et al.
Page
of 11